Diabetics

Amaryl

Amaryl

Glimepiride is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Glimepiride lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently. This medication will only help lower blood sugar in people whose bodies produce insulin naturally. Glimepiride is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may occur if high blood sugar is not treated).
Glimer

Glimer

GLIMER is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with non insulin-dependent (Type 2) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone. GLIMER may be used concomitantly with metformin when diet, exercise, and glimepiride or metformin alone do not result in adequate glycaemic control. GLIMER is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent. Combined use of glimepiride and insulin may increase the potential for hypoglycaemia.

Glyciphage

Glyciphage

GLYCIPHAGE is an oral antidiabetic drug belonging to the biguanide group. GLYCIPHAGE overcomes insulin resistance and it has an extra-pancreatic peripheral action. It does not produce hypoglycaemia in normal subjects.

GLYCIPHAGE has fibrinolytic activity which has prophylactic and therapeutic value in various vascular complications of diabetes. e.g. Coronary artery disease, cerebrovascular accidents and peripheral vascular disease.

 

Indications:

  1. Type 2 diabetes patients not responding to dietary regulations and physical exercise, should be put on GLYCIPHAGE as the first line treatment.

  2. In IGT.
  3. In combination with insulin secretagogues, glitazones and adjuvant to insulin therapy.
  4. In PCOS.
  5. In essential hypertension.

 

Pioz MF - 15

Pioz MF - 15

SR Tablet - Pioglitazone 15mg + Metformin 500 mg  ( Sustained Release )

TriObimet Tablets

TriObimet Tablets

TriObimet tablets, used as a once per day, are indicated as an adjunct to diet and exercise, to lower blood glucose. It is indicated as second-line therapy when diet, exercise, single agents and dual combination therapy do not result in adequate glycaemic control in patients with type 2 diabetes.

  • 1
  • 2